KV Pharma To Shell Out $17M In FCA Settlement
By Christopher Norton · December 6, 2011, 6:42 PM EST
KV Pharmaceutical Co. agreed Tuesday to pay $17 million to resolve a former subsidiary's role in a long-running False Claims Act qui tam action alleging it wrongly reported to Medicaid and...
To view the full article, register now.